These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 15127371)

  • 41. Promises and challenges of pneumococcal conjugate vaccines for the developing world.
    Grijalva CG; Edwards KM
    Clin Infect Dis; 2006 Sep; 43(6):680-2. PubMed ID: 16912938
    [No Abstract]   [Full Text] [Related]  

  • 42. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults.
    Korsgaard J; Møller JK; Kilian M
    Int J Infect Dis; 2005 Sep; 9(5):274-9. PubMed ID: 16095941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The need for prudent use of antibiotics and routine use of vaccines.
    Cohen R
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():21-3. PubMed ID: 19366366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic options for pneumococcal pneumonia in Turkey.
    Oncu S; Erdem H; Pahsa A
    Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance.
    Ferrara AM
    Infection; 2005 Jun; 33(3):106-14. PubMed ID: 15940410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children.
    Park SY; Moore MR; Bruden DL; Hyde TB; Reasonover AL; Harker-Jones M; Rudolph KM; Hurlburt DA; Parks DJ; Parkinson AJ; Schuchat A; Hennessy TW
    Pediatr Infect Dis J; 2008 Apr; 27(4):335-40. PubMed ID: 18316986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
    Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
    Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era.
    Pichichero ME; Casey JR
    Pediatr Infect Dis J; 2007 Oct; 26(10 Suppl):S12-6. PubMed ID: 18049375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Geographically-based evaluation of multidrug resistance trends among Streptococcus pneumoniae in the USA: findings of the FAST surveillance initiative (2003-2004).
    Draghi DC; Jones ME; Sahm DF; Tillotson GS
    Int J Antimicrob Agents; 2006 Dec; 28(6):525-31. PubMed ID: 17101260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High nasopharyngeal carriage of drug resistant Streptococcus pneumoniae and Haemophilus influenzae in North Indian schoolchildren.
    Jain A; Kumar P; Awasthi S
    Trop Med Int Health; 2005 Mar; 10(3):234-9. PubMed ID: 15730507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.
    File TM; Garau J; Jacobs MR; Wynne B; Twynholm M; Berkowitz E
    Int J Antimicrob Agents; 2005 Feb; 25(2):110-9. PubMed ID: 15664480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in Austria.
    Buxbaum A; Forsthuber S; Graninger W; Georgopoulos A;
    J Antimicrob Chemother; 2004 Jul; 54(1):247-50. PubMed ID: 15140858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003).
    Johnson DM; Stilwell MG; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):69-74. PubMed ID: 16546341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children and multidrug resistance].
    Bayer M; Aslan G; Emekdaş G; Kuyucu N; Kanik A
    Mikrobiyol Bul; 2008 Apr; 42(2):223-30. PubMed ID: 18697420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN; Sader HS; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
    Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibiotic resistance: the Iowa experience.
    Bell N
    Am J Manag Care; 2002 Nov; 8(11):988-94. PubMed ID: 12437313
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
    Deshpande LM; Sader HS; Debbia E; Nicoletti G; Fadda G; Jones RN;
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):157-64. PubMed ID: 16423493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotic resistance after licensure of pneumococcal 7-valent conjugate vaccine.
    Robertson JL; Rasnake M
    Clin Infect Dis; 2006 Aug; 43(4):544; author reply 544-5. PubMed ID: 16838251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.